TOP

News

Arkis BioSciences News

Arkis BioSciences completes FDA registration and listing!

Arkis BioSciences completed FDA establishment registration Monday and listing of its Tunneling Guidewire instrument facilitating market introduction.  Arkis’ Tunneling Guidewire now offers physicians and hydrocephalus patients a next generation surgical solution for less invasive shunt implantations, reducing neck incisions and surgical durations.

 

Read More

Arkis BioSciences selected to present at VS West 2015!

Join Arkis in the valley! Arkis selected to present among the nation’s Top 50 Innovators convening at Venture Summit West, San Francisco, February 10th-11th. Arkis will be presenting exciting news along with the latest updates of our commitment for revolutionizing patient care!

 

Read More

Arkis invited to present at the 15th annual New York Venture Summit!

Arkis is honored to be invited to present at this year’s NY Venture Summit, June 23 – 24th, at The Digital Sandbox.  Be sure to visit us in the Big Apple and learn the latest news as Arkis continues to roll out its product portfolio advancing treatments for intracranial hypertension.

 

Read More

Arkis presenting the latest at the 2015 annual SEMDA conference…

Arkis will be sharing the latest company news at this year’s SEMDA annual conference for “Smart Devices + Smart Medicine” March 31st and April 1st, 2015 where we’ll be speaking about Arkis’ exclusive offering of its new FDA listed Tunneling Guidewire surgical instrument – the first of its kind for less invasive shunt procedures, as […]

 

Read More

Arkis BioSciences selected as a Top 50 Showcase Company at SEVC 2015!

Join Arkis at this year’s Southeastern Venture Conference where we’ll be presenting as a Top 50 Showcase Company in Charlotte, NC and sharing exciting news of Arkis’ latest offerings including its Tunneling Guidewire surgical instrument, providing less invasive shunt implantations!

 

Read More

Tech-20/20 Venture Exchange

Arkis presents at Tech-20/20’s Venture Exchange hosted by Pershing Yoakley & Associates P.C.  March 21, 2013.

 

Read More

SEMDA Invitation

Arkis BioSciences is invited to SEMDA 2014, as CEO, Chad Seaver, presents Arkis’ latest developments. April 16, 2014.

 

Read More

LaunchTN’s Medical Device Venture Match

Arkis BioSciences presents at LaunchTN’s Medical Device Venture Match hosted by the Provision Center for Proton Therapy and sponsorred by Bass Berry & Sims.  February 25, 2014.

 

Read More

“Stock News Now” Features Arkis Biosciences

Arkis’ CMO, Dr. Killeffer, interviews with Stock News Now, sharing the Arkis story. May 8, 2014.

 

Read More

“Teknovation.biz” Features Arkis Biosciences

Arkis’ CEO interviews with Tom Ballard, Director of Innovation and Entrepreneurial Initiatives of Pershing Yoakley & Associates P.C. Teknovation.biz column.  October 27, 2013.

 

Read More

Contact Us

Address: 1 Momentum Way, Knoxville, TN 37920 | Tel: (844) 247-5383 (toll free)

© 2013-2018  Arkis BioSciences Inc.  All rights reserved.   |   Privacy   |   Sitemap

Arkis BioSciences is ISO 13485:2016 certified for its Medical Device Quality Management System by TUV USA, Inc. (Member of TUV NORD Group).

Go to top